Paper Details

  1. Home
  2. Paper Details

Influenza.

Author: KhareM D, SharlandM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Zanamivir and oseltamivir, neuraminidase inhibitors, are effective in preventing influenza A and B infections. They reduce illness duration by 1-1.5 days when started within 36-48 hours of illness onset. They have minimal side effects and do not affect the central nervous system. Zanamivir is administered via inhalation, while oseltamivir is taken orally. More research is needed to compare their efficacy, cost-effectiveness, and use in high-risk groups.
Paper Details　
Original Abstract of the Article :
The currently available antiviral drugs rimantadine and amantadine are effective only for influenza A viruses. Another class of influenza antiviral drugs is the neuraminidase inhibitors, which selectively inhibit both influenza A and B viruses. Recent studies have found the neuraminidase inhibitors ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14656566.1.3.367

データ提供：米国国立医学図書館（NLM）

Fighting the Flu: A Look at Antiviral Medications

Influenza, a common respiratory illness, can cause significant morbidity and mortality, especially in vulnerable populations. This article reviews the effectiveness and safety of antiviral medications for influenza, focusing on the neuraminidase inhibitors zanamivir and oseltamivir. The authors discuss the mechanisms of action of these drugs and their potential benefits in preventing and treating influenza infection.

Neuraminidase Inhibitors: A Powerful Weapon Against the Flu

The study highlights the efficacy of neuraminidase inhibitors in preventing and treating influenza infection. Zanamivir and oseltamivir have been shown to reduce the duration of illness and prevent laboratory-confirmed infection when administered as prophylaxis. The authors emphasize the minimal adverse effects of these drugs, particularly in comparison to amantadine and rimantadine. However, they acknowledge the need for further research to optimize their use and to determine their cost-effectiveness.

Navigating the Flu Season

This article provides valuable insights into the current landscape of influenza treatment, emphasizing the importance of antiviral medications in managing this common illness. The authors highlight the efficacy and safety of neuraminidase inhibitors, but also emphasize the need for ongoing research to further refine treatment strategies and optimize patient outcomes. This information is crucial for healthcare professionals and individuals alike, empowering them to make informed decisions about influenza prevention and treatment.

Dr.Camel's Conclusion

Just as a camel navigates the harsh desert climate, we face the challenges of infectious diseases, like influenza. This article sheds light on the effectiveness of neuraminidase inhibitors, providing hope for better prevention and treatment of this common illness. It's important to stay informed about the latest research and to consult with healthcare professionals to make informed decisions about our health during flu season.

Date :
  1. Date Completed 2001-04-05
  2. Date Revised 2019-09-15
Further Info :

Pubmed ID

11249523

DOI: Digital Object Identifier

10.1517/14656566.1.3.367

Related Literature

Article Analysis
・Effects of zanamivir oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.